Results 131 to 140 of about 136,697 (349)

Opioid Dose Trajectories and Associations With Mortality, Opioid Use Disorder, Continued Opioid Therapy, and Health Plan Disenrollment [PDF]

, 2022
Ingrid A. Binswanger, Susan Shetterly, Stanley Xu, Komal J. Narwaney, David L. McClure, Deborah Rinehart, Anh P. Nguyen, Jason M. Glanz   +7 more
openalex   +1 more source

Patient‐ and Clinician‐Related Factors Associated With the Reduction in Opioid Use Among Adults With Chronic Non‐Cancer Pain: A Systematic Review

Clinical Pharmacology &Therapeutics, EarlyView.
Despite known risks, opioids are widely used for chronic non‐cancer pain (CNCP). Clinical guidelines now recommend deprescribing, but factors predicting success are poorly understood. This systematic review aimed to identify clinician and patient factors associated with attaining successful opioid dose reduction or discontinuation in adults with CNCP ...
Alessandra C. Marcelo, Sarah N. Hilmer, David J. Hunter, Stephanie Mathieson, Riyaas Mohamed, Leo Li, Natalie Fung, Anthony Yue, Manuela L. Ferreira   +8 more
wiley   +1 more source

Characterizing app-based telemedicine for opioid use disorder treatment within the landscape of recovery-related smartphone applications

Addiction Science & Clinical Practice
A 2025 qualitative content analysis by Williamson et al. evaluated tools available through smartphone apps to support patients with recovery from opioid use disorder.
Lauren E. Hendy, Eileen Barrett, Cynthia Jimes, M. Justin Coffey, Marlene C. Lira   +4 more
doaj   +1 more source

Clinical Impact of an Expanded MOUD Access Initiative for Patients Hospitalized With Infections From Intravenous Opioid Use

American Journal of Medicine Open
Background: Despite their efficacy, medications for opioid use disorder (MOUD) remain underutilized in patients with infections from intravenous opioid use (I-IOU).
Jack Keegan, William Peppard, Rebecca Bauer, Mary Beth Alvarez, Kimberly Stoner, Jennifer McNeely   +5 more
doaj   +1 more source

An Exploratory Study of Suboxone (Buprenorphine/ Naloxone) Film Splitting: Cutting Methods, Content Uniformity, and Stability [PDF]

, 2019
Suboxone films are U.S. Food and Drug Administration approved to treat opioid dependence. While the package insert states that films should not be cut, physicians often prescribe film fractions for treatment and tapering. There is no data to support this
Conn, Kelly, Corigliano, Anthony, DeAngelis, Michael J., Ferrara, Alexander S., Phillips, Elizabeth, Reindel, Kristin L., Zhao, Fang   +6 more
core   +1 more source

Patient Engagement and Opinions of a Medication Assisted Treatment Program for Opioid Use Disorder: A Qualitative Assessment [PDF]

, 2020
Introduction: Opioid use disorder is widely regarded as a national health epidemic. Stephen Klein Wellness Center 6as started a Medication-Assisted Treatment (MAT) program to help combat this epidemic- a program that is unique in that it does not require
Wagoner, Sarah, Weinstein, MD, Lara
core   +1 more source

Increasing Access to Medication-Assisted Treatment for Opioid Use Disorders: Estimating Costs, Supply, and the Effects of Insurance Expansions [PDF]

, 2017
Ervant Maksabedian Hernandez
openalex   +1 more source

Opioid Toxicity Following Concomitant Use of Macrolide Antibiotics with Fentanyl, Hydromorphone, or Oxycodone: A Population‐Based Study

Clinical Pharmacology &Therapeutics, EarlyView.
Fentanyl, hydromorphone, and oxycodone are metabolized by cytochrome P450 3A4 (CYP3A4). Co‐administration with CYP3A4‐inhibiting macrolides (clarithromycin or erythromycin) may increase opioid concentrations and overdose risk, but the clinical impact of these interactions is unknown.
Tony Antoniou, Joanna Yang, David N. Juurlink, Joanne M.‐W. Ho, Muhammad Mamdani, Fangyun Wu, Mina Tadrous, Tara Gomes   +7 more
wiley   +1 more source

A Study of the Connection between the Affordable Care Act and the Economic Burden of the US Produced by the Opioid Epidemic [PDF]

, 2019
Undergraduate Biomedical ...
Jang, Er Yearn
core   +1 more source

Maintenance on extended-release naltrexone is associated with reduced injection opioid use among justice-involved persons with opioid use disorder [PDF]

, 2022
Audun J Lier, Nikhil Seval, Brent Vander Wyk, Angela Di Paola, Sandra A. Springer   +4 more
openalex   +1 more source